Noven Pharma (Weighted Average Cost of Capital (WACC) Analysis)
 Improve your investment analysis with by seeing the Noven Pharma's Discounted Cash Flow analysis, Noven Pharma's Warren Buffet analysis, and Noven Pharma's Comparable Multiple analysis.  Helpful Information for Noven Pharma's AnalysisWhat is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine Noven Pharma's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for Noven Pharma. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in Noven Pharma before they make value investing decisions. This WACC analysis is used in Noven Pharma's discounted cash flow (DCF) valuation and see how the WACC calculation affect's Noven Pharma's company valuation. |
WACC Analysis Information1. The WACC (discount rate) calculation for Noven Pharma uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for Noven Pharma over the long term. If there are any short-term differences between the industry WACC and Noven Pharma's WACC (discount rate), then Noven Pharma is more likely to revert to the industry WACC (discount rate) over the long term. 2. The WACC calculation uses the higher of Noven Pharma's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and Noven Pharma uses a significant proportion of equity capital. |